Related Experiment Video
Updated: Apr 24, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Abstract:
A phase II trial of the MEK inhibitor selumetinib offers hope for patients with metastatic uveal melanoma, a rare and fatal eye cancer.
Insights
A phase II trial investigated selumetinib for metastatic uveal melanoma. This MEK inhibitor shows promise in treating this rare and deadly eye cancer.
Area of Science:
- Oncology
- Ophthalmology
- Pharmacology
Background:
- Metastatic uveal melanoma is a rare and aggressive eye cancer with limited treatment options.
- Current therapies for metastatic uveal melanoma have shown modest efficacy.
Purpose of the Study:
- To evaluate the efficacy and safety of the MEK inhibitor selumetinib in patients with metastatic uveal melanoma.
Main Methods:
- A phase II clinical trial was conducted.
- Patients with metastatic uveal melanoma received selumetinib.
Main Results:
- Selumetinib demonstrated promising activity in patients with metastatic uveal melanoma.
- The study assessed response rates and safety profiles.
Conclusions:
- Selumetinib offers a potential new therapeutic option for patients battling metastatic uveal melanoma.
- Further investigation is warranted to confirm these findings.
More Related Videos
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers